Company Overview

Development Stage

About the Company

[Summary] POCT诊断技术产业化及产业研究

北京英诺特生物技术股份有限公司成立于2006年,是集研发、生产和销售于一体的体外诊断试剂国家高新技术企业、中关村高新技术企业。
2020年9月8日,英诺特荣获中共中央、国务院、中央军委表彰的全国抗击新冠肺炎疫情先进集体。
2020年初新型冠状病毒肺炎疫情发生后,公司依托呼吸道病原体检测领域的技术优势,开展新冠病毒检测产品研发,产品于同年2月22日取得国内首批新冠病毒IgM/IgG抗体检测试剂盒注册证。随后公司参与了3项《新型冠状病毒(2019-nCoV)抗体检测试剂盒》国家标准的制定。
2020年2月,公司将首批生产的5万人份新冠抗体检测试剂火速捐给了武汉。2020年3月,中央赴湖北等疫情严重地区指导组医疗救治组向公司发来感谢函,充分肯定了公司捐赠的试剂盒在疫情防控中发挥的积极作用。
2021年1月,公司向河北省捐赠30万人份新冠抗体检测试剂,共舟共“冀”、共克“石”艰。
公司新冠产品中标京津冀、黑吉辽等多省市集采,为疫情防控做出了应有的贡献。
公司拥有免疫层析平台、间接免疫荧光平台、液相免疫平台、核酸分子检测平台、基因重组蛋白工程平台以及细胞和病原体培养平台6大技术平台,拥有国家发明专利15项,全部产品为自主研发,拥有自主知识产权。目前,公司已取得64项国内医疗器械产品注册/备案证,其中三类医疗器械注册证53项,在呼吸道病原体联检领域建了较强的市场优势。还取得了包括FDA的EUA授权在内的多个海外市场准入许可,支援全球抗疫。
公司建有北京和唐山两个生产基地,在生产线布局、设备选型、设备安装、调试、验证方面均具有丰富的经验。
公司产品质量广受好评,畅销全国,并远销欧盟、俄罗斯、日本、澳大利亚、新加坡、巴西、东南亚等70多个国家和地区,为世界抗疫事业,做出了中国企业应有的贡献。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

英诺特生物股份 Financing History (2 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

英诺特生物股份 How Fast Is Hiring Growing? (46 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 45%
  • 2024: Up 230%
  • 2023: Down 3%
  • 2022: Up 278%
英诺特生物股份 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
英诺特生物股份 Campus Recruitment & Advanced Degree Talent Demand
Master's 3
Note: How fast is hiring at 北京英诺特生物技术股份有限公司 growing? 英诺特生物股份2025: 158 openings (up 45%), 2024: 109 openings (up 230%), 2023: 33 openings (down 3%), 2022: 34 openings (up 278%), 2021: 9 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

英诺特生物股份 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Up 233%
  • 2023: Flat 0%-
英诺特生物股份 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 北京英诺特生物技术股份有限公司 growing? 英诺特生物股份Master's recruitment over the years: 2025: 10 openings (flat), 2024: 10 openings (up 233%), 2023: 3 openings (flat), 2022: 3 openings.

英诺特生物股份 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
英诺特生物股份 Doctoral Hiring by Year: 2023 — same as 2022
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 北京英诺特生物技术股份有限公司 growing? 英诺特生物股份Doctorate recruitment over the years: 2023: 1 openings (flat), 2022: 1 openings.

英诺特生物股份 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 北京英诺特生物技术股份有限公司? Based on an analysis of 英诺特生物股份's job postings over the past year, "计算机/网络/技术类" demand: 15.3%, "其他(研发和技术类)": 11.9%, "生物/制药/化工/环保类": 5.9%, "医疗卫生/美容保健类": 5.1%, "美术/设计/创意类": 0.8%. For reference only.

英诺特生物股份 — What Are the Salaries Like? (118 records)

Manage
英诺特生物股份 Salary Overview
salary range: 3K - 50K, 42.4% of roles pay ¥20-50K
Note: salary statistics are based on 118 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 北京英诺特生物技术股份有限公司?英诺特生物股份42.4% of positions earn 20-50K, Undergraduate salary: ¥。销售类 average salary ¥18.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 英诺特生物股份

(More)
Are salaries high at 北京英诺特生物技术股份有限公司? We provide: 销售,运营,市场,财务,医疗器械,大区经理,实习生,研发工程师,化学,研发经理,产品经理,分析,技术支持,质量,采购,bp,仓储,会计,供应链,剪辑. Click to view detailed salary analysis by job.

英诺特生物股份 — Fortune 500? (More)

Yes, ranked in 中国高新技术企业慈善公益500强:

英诺特生物股份 honors, qualifications & industry associations

英诺特生物股份 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    30.5% of total 30.5%
  • 经营管理类
    25.5% of total 25.5%
  • 客户服务类
    16.3% of total 16.3%
  • 计算机/网络/技术类
    15.6% of total 15.6%

Education

  • 本科
    69.5% of total 69.5%
  • 大专
    23.4% of total 23.4%
  • 硕士
    6.4% of total 6.4%
  • 不限
    0.7% of total 0.7%

Experience

  • 5-10年
    50.4% of total 50.4%
  • 不限
    19.9% of total 19.9%
  • 3-5年
    17.7% of total 17.7%
  • 1-3年
    12.1% of total 12.1%
View Detailed Analysis

What does 北京英诺特生物技术股份有限公司 require? Who is 英诺特生物股份 hiring? 英诺特生物股份 recruitment: 销售类占比最多占30.5%,其次是经营管理类占25.5%. What education can get in at 英诺特生物股份? 本科占比最多占69.5%,其次是大专占23.4%. High education required at 英诺特生物股份? 硕士占6.4%. Work experience required at 英诺特生物股份? 5-10年占比最多占50.4%,其次是不限占19.9%. Where are the job locations at 英诺特生物股份? 北京占比最多占60.3%,其次是杭州占17.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 13,645.8196万(元)
Legal Representative: 张秀杰
Date Established:
Credit Code: 911101067855339571
Registered Address: 北京市丰台区海鹰路1号院6号楼1层2层

Partners & Suppliers

供应快速诊断试剂组件及包装材料 Source
供应商 试剂组件及耗材
提供抗原抗体原料 Source
供应商 抗原抗体原料
提供抗原抗体原料 Source
供应商 抗原抗体原料
提供抗原抗体等核心生物原料 Source
供应商 抗原抗体原料
经销商,采购公司体外诊断试剂 Source
合作客户 经销商

People who follow 英诺特生物股份 also follow

英诺特生物股份 Competitors (Similar Companies)

医药 体外诊断试剂 诊断试剂 生物化学
生物科技/生物工程 抗体 诊断试剂 试剂
试剂 抗体 体外诊断试剂 生物制品
生物科技/生物工程 试剂 生物试剂 体外诊断试剂
“Advancing medical science to help people live healthier lives”
自动化 物流自动化 工业自动化 自动化设备
“一家致力于为社会大众提供二手房、新房、租赁、金融产品等房产交易服务”
“镁合金、铝合金压铸生产、精密机械加工,模具设计与制造”
传媒 文化传媒 营销服务 创新服务
生产 汽车用品 汽车内饰 汽车饰件
动力总成 汽车零部件/配件 通风设备 夹具
“Let the light of life science shine into every corner of the earth”
“A domestic first-class, internationally renowned biotechnology enterpr”
诊断试剂 试剂 分子诊断试剂 体外诊断仪器

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates